1. Home
  2. SVM vs HROW Comparison

SVM vs HROW Comparison

Compare SVM & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$8.90

Market Cap

1.4B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$50.09

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
HROW
Founded
N/A
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SVM
HROW
Price
$8.90
$50.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$9.00
$68.86
AVG Volume (30 Days)
5.7M
536.8K
Earning Date
02-10-2026
11-10-2025
Dividend Yield
0.28%
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$323,391,000.00
$250,042,000.00
Revenue This Year
$22.28
$38.96
Revenue Next Year
$32.53
$43.38
P/E Ratio
$75.24
N/A
Revenue Growth
33.99
47.83
52 Week Low
$2.88
$20.85
52 Week High
$9.17
$51.30

Technical Indicators

Market Signals
Indicator
SVM
HROW
Relative Strength Index (RSI) 66.09 65.25
Support Level $8.37 $44.19
Resistance Level $9.17 $50.65
Average True Range (ATR) 0.45 2.35
MACD -0.00 0.15
Stochastic Oscillator 79.79 84.79

Price Performance

Historical Comparison
SVM
HROW

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: